Total Funding
89
59
Total FundingPost-IPO Equity raised
Growth Score
-8 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74612
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
- Christian Angermayer: FounderPast Role: FinLab, Founder
- Manoj Doss: Sub-Investigator
About the Company
AtaiBeckley is a biopharmaceutical company that develops rapid-acting mental-health therapies. Its pipeline includes an intranasal mebufotenin benzoate candidate (BPL-003) for treatment-resistant depression, a DMT buccal film, and an oral R-MDMA compound . The company conducts clinical trials and drug development in neuropsychiatric conditions.
